All G is gearing up to launch its first product—recombinant bovine lactoferrin—in Q1 2026, says CEO Jan Pacas.
Investors “don't always have the time to do the perfect analysis of why we are saying 'no,' but we try really hard,” says PINC’s Marika King.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback